TY - JOUR
KW - medication-assisted treatment
KW - medication-based treatment
KW - buprenorphine
KW - telebehavioral health
KW - Telemedicine
AU - E. Weintraub
AU - A. D. Greenblatt
AU - J. Chang
AU - C. J. Welsh
AU - A. P. Berthiaume
AU - S. R. Goodwin
AU - R. Arnold
AU - S. S. Himelhoch
AU - M. E. Bennett
AU - A. M. Belcher
A1 - 
AB - This report builds on a previous study that describes the collaboration between an urban academic medical center and a rural drug treatment center, the goal of which is to provide medication-based treatment to individuals with OUD via videoconferencing. We describe results of a retrospective chart review of 472 patients treated in the program between August 2015 and April 2019. We examined several demographic and substance use variables for individuals who consented to telemedicine treatment, retention in treatment over time, and opioid use over time to understand further the impact of prescribing buprenorphine and naltrexone via telemedicine to patients in a rural OUD treatment setting. Our findings support the effectiveness of prescribing medications via telemedicine. The inclusion of more than three times as many patients as in our prior report revealed retention rates and toxicology results that are comparable to face-to-face treatment. These findings have implications for policymakers and clinicians considering implementation of similar programs.
AD - Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Medical School Training Program, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Division of Psychiatric Services Research, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Division of Psychiatric Services Research, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Department of Psychiatry, University of Kentucky College of Medicine, Lexington, KY 40509, USA.; Division of Psychiatric Services Research, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.; Division of Addiction Research and Treatment, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
BT - Heroin addiction and related clinical problems
C5 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
CP - 2
IS - 2
JF - Heroin addiction and related clinical problems
LA - eng
M1 - Journal Article
N2 - This report builds on a previous study that describes the collaboration between an urban academic medical center and a rural drug treatment center, the goal of which is to provide medication-based treatment to individuals with OUD via videoconferencing. We describe results of a retrospective chart review of 472 patients treated in the program between August 2015 and April 2019. We examined several demographic and substance use variables for individuals who consented to telemedicine treatment, retention in treatment over time, and opioid use over time to understand further the impact of prescribing buprenorphine and naltrexone via telemedicine to patients in a rural OUD treatment setting. Our findings support the effectiveness of prescribing medications via telemedicine. The inclusion of more than three times as many patients as in our prior report revealed retention rates and toxicology results that are comparable to face-to-face treatment. These findings have implications for policymakers and clinicians considering implementation of similar programs.
PY - 2021
SN - 1592-1638; 1592-1638
SP - 5
EP - 12
EP - 
T1 - Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review
T2 - Heroin addiction and related clinical problems
TI - Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: A retrospective chart review
U1 - Education & Workforce; HIT & Telehealth; Opioids & Substance Use
U2 - 33551692
VL - 23
VO - 1592-1638; 1592-1638
Y1 - 2021
ER -